Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2023 Jul 31.

Published in final edited form as: AJR Am J Roentgenol. 2021 Aug 25;218(2):342–350. doi: 10.2214/AJR.21.26071

TABLE 1:

Comparison Among Imaging Modalities of Conspicuity Score and Positivity Rate for Sporadic Adrenal Pheochromocytoma

		Conspicuity Score		Positivity Rate
Modality	No. of Patients	Mean ± SD	Median (Range)	Raw Data	Percentage (95% CI)
⁶⁸Ga-DOTATATE PET/CT	14	4.4 ± 1.0	5.0 (2.0–5.0)	11/14	78.6 (49.2–95.3)
FDG PET/CT	14	4.1 ± 1.5	5.0 (1.0–5.0)	11/14	78.6 (49.2–95.3)
¹⁸F-FDOPA PET/CT	11	5.0 ± 0.0	5.0 (5.0–5.0)	11/11	100 (71.5–100)
¹⁸F-FDA PET/CT	7	4.6 ± 0.8	5.0 (3.0–5.0)	6/7	85.7 (42.1–99.6)
Portal venous phase CT	12	4.3 ± 1.0	5.0 (3.0–5.0)	8/12	66.7 (34.9–90.1)
MRI	12	4.7 ± 0.5	5.0 (4.0–5.0)	12/12	100 (73.5–100)